Immunoprecise Stock Math Transform Inverse Tangent Over Price Movement

IPA -  USA Stock  

USD 4.14  0.15  3.50%

Immunoprecise Antibodies math transform tool provides the execution environment for running the Inverse Tangent Over Price Movement transformation and other technical functions against Immunoprecise Antibodies. Immunoprecise Antibodies value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of math transform indicators. As with most other technical indicators, the Inverse Tangent Over Price Movement transformation function is designed to identify and follow existing trends. Analysts that use price transformation techniques rely on the belief that biggest profits from investing in Immunoprecise Antibodies can be made when Immunoprecise Antibodies shifts in price trends from positive to negative or vice versa.

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Immunoprecise Antibodies Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Immunoprecise Antibodies price patterns.
.

Immunoprecise Antibodies Technical Analysis Modules

Most technical analysis of Immunoprecise Antibodies help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Immunoprecise from various momentum indicators to cycle indicators. When you analyze Immunoprecise charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Immunoprecise Antibodies Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Immunoprecise Antibodies. We use our internally-developed statistical techniques to arrive at the intrinsic value of Immunoprecise Antibodies based on widely used predictive technical indicators. In general, we focus on analyzing Immunoprecise Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Immunoprecise Antibodies's daily price indicators and compare them against related drivers, such as math transform and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Immunoprecise Antibodies's intrinsic value. In addition to deriving basic predictive indicators for Immunoprecise Antibodies, we also check how macroeconomic factors affect Immunoprecise Antibodies price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2020 2021 2022 (projected)
Book Value per Share3.463.973.25
Asset Turnover0.380.340.36
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Immunoprecise Antibodies' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Immunoprecise Antibodies in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.214.198.99
Details
Intrinsic
Valuation
LowReal ValueHigh
1.426.2211.02
Details
Naive
Forecast
LowNext ValueHigh
0.083.798.60
Details
1 Analysts
Consensus
LowTarget PriceHigh
12.0012.0012.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Immunoprecise Antibodies. Your research has to be compared to or analyzed against Immunoprecise Antibodies' peers to derive any actionable benefits. When done correctly, Immunoprecise Antibodies' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Immunoprecise Antibodies.

Learn to be your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Fund Screener Now

   

Fund Screener

Find actively-traded funds from around the world traded on over 30 global exchanges
All  Next Launch Module

Immunoprecise Antibodies pair trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Immunoprecise Antibodies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunoprecise Antibodies will appreciate offsetting losses from the drop in the long position's value.

Immunoprecise Antibodies Pair Trading

Immunoprecise Antibodies Pair Trading Analysis

The ability to find closely correlated positions to Immunoprecise Antibodies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Immunoprecise Antibodies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Immunoprecise Antibodies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Immunoprecise Antibodies to buy it.
The correlation of Immunoprecise Antibodies is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Immunoprecise Antibodies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Immunoprecise Antibodies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Immunoprecise Antibodies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please see Risk vs Return Analysis. Note that the Immunoprecise Antibodies information on this page should be used as a complementary analysis to other Immunoprecise Antibodies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Transformation module to use Price Transformation models to analyze depth of different equity instruments across global markets.

Complementary Tools for Immunoprecise Stock analysis

When running Immunoprecise Antibodies price analysis, check to measure Immunoprecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunoprecise Antibodies is operating at the current time. Most of Immunoprecise Antibodies' value examination focuses on studying past and present price action to predict the probability of Immunoprecise Antibodies' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immunoprecise Antibodies' price. Additionally, you may evaluate how the addition of Immunoprecise Antibodies to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Is Immunoprecise Antibodies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunoprecise Antibodies. If investors know Immunoprecise will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunoprecise Antibodies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
101.5 M
Quarterly Revenue Growth YOY
0.066
Return On Assets
-0.19
Return On Equity
-0.43
The market value of Immunoprecise Antibodies is measured differently than its book value, which is the value of Immunoprecise that is recorded on the company's balance sheet. Investors also form their own opinion of Immunoprecise Antibodies' value that differs from its market value or its book value, called intrinsic value, which is Immunoprecise Antibodies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunoprecise Antibodies' market value can be influenced by many factors that don't directly affect Immunoprecise Antibodies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunoprecise Antibodies' value and its price as these two are different measures arrived at by different means. Investors typically determine Immunoprecise Antibodies value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunoprecise Antibodies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.